Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by jfm1330on Mar 01, 2021 5:28pm
99 Views
Post# 32691048

RE:RE:RE:RE:RE:RE:RE:RE:Just thought I would pass this along

RE:RE:RE:RE:RE:RE:RE:RE:Just thought I would pass this alongPlease, stop talking about Warren Buffet when talking about a speculative biopharma company. Buffet never invested in this kind of speculative companies. Also, if stock corporate options programs are making are making you sick, forget the the biotech sector. This is everywhere. Do I like it? No. But this is the way it is, and talking specifically about Thera, much more options given through this program went expired.

Another thing about all this dilution thing and being robbed of value and all that. One thing I learned with Thera, is that personal buy/sell decisions and timing are much important to get value than the long term performance of the stock since it never achieved financal success.


<< Previous
Bullboard Posts
Next >>